Hello, Welcome to Shine Consultant !
Summit & Event Shine Speaker Bureau Shine Advisor Shine Event Service
  • Summit & Event :
    With field research of markets and industries which is analyzed from a global strategic perspective by our professional teams, as well as hot topics which interest leadership and management, Shine Consultant provides you with one-stop platform of dialogue, practice -sharing and social network!
  • Shine Speaker Bureau:
    Committed to provide keynote speakers, executive learning masterclasses and boardroom advisory for global enterprises and institutions, each service provides a deeper and more interactive experience, especially for small, selected audiences and key individuals. We have the resources of the most influential business leaders and experts, who are the most outstanding representatives in their fields. Our team consists of experienced speech and event managers, and we focus on building long-term and in-depth partnerships.
  • Shine Advisor:
    As world-class insight network, we connects clients-decision makers with vetted subject matter experts-advisors. Our clients leverage the insights and perspectives shared by our advisors to stay informed and make better business decisions.We have over 600,000 Shine Advisors in 20 industries, which continues to grow every day.
  • Shine Event Service:
    Committed to be the world's most professional provider of industrial Summit & Event. We provide one-stop professional services, including investigating and planning, on-demand inviting, marketing and promoting, operating, project management, live& digital conference, each service is performed by an experienced professional team matched with long-term industrial resources. We focus on establishing long-term and in-depth partnerships.
Guest Information
Michael CHEN
Michael CHEN
Positions:

Head of External Innovation China

Company:

Merck Serono (Beijing) Pharmaceutical R&D Co., Ltd. 

Dr. Chen Chen (Michael) currently works as Head of External Innovation China and APAC for Merck KGaA. Michael leads collaborations with academic institutions and local pharmaceutical companies in China and APAC areas with alignment of Merck R&D focus and requirement. He encompasses scouting and evaluation of external opportunities including assets from discovery to clinical development stages, new drug target/biomarker findings, and novel discovery technologies, through open innovation, licensing, co-development, investment and other collaboration models. He also provides his duties within Merck global BD team for various internalization and externalization opportunities.

 

Michael received his bachelor degree in cell and molecular biology from University of Essex, a master degree in cancer immunotherapy from University of Nottingham and a PhD in Biochemistry from Imperial College London. Before joining Merck, he has been leading research projects at Spirogen Ltd./MedImmune, and involved in business development/investment activities at WuXi AppTec and ChemPartner.